Jose Ramon Gonzalez Porras

Summary

Publications

  1. ncbi request reprint Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation
    Jose Ramon Gonzalez-Porras
    Department of Hematology, University Hospital of Salamanca, Spain
    Blood Coagul Fibrinolysis 17:23-8. 2006
  2. ncbi request reprint Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism
    J R Gonzalez-Porras
    Department of Hematology, University Hospital of Salamanca, Paseo de San Vicente, 58 182, Salamanca, 37007, Spain
    Thromb Res 119:691-8. 2007
  3. ncbi request reprint Homocysteine and outcome in young patients with acute coronary syndromes
    Francisco Martin-Herrero
    Cardiology Department, University Hospital, Salamanca, Spain
    Int J Cardiol 118:183-8. 2007

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation
    Jose Ramon Gonzalez-Porras
    Department of Hematology, University Hospital of Salamanca, Spain
    Blood Coagul Fibrinolysis 17:23-8. 2006
    ..6% (95% confidence interval, 0.2-0.9). We have identified a group of patients with DVT but at very low risk of re-thrombosis in whom an extended secondary thromboprophylaxis should be carefully considered...
  2. ncbi request reprint Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism
    J R Gonzalez-Porras
    Department of Hematology, University Hospital of Salamanca, Paseo de San Vicente, 58 182, Salamanca, 37007, Spain
    Thromb Res 119:691-8. 2007
    ..37 mumol/L) [HR=2.5; (95% CI, 1.1-4.7); p=0.04]. Elevated plasma homocysteine level at admission is an independent risk factor for RCE after the first episode of ACS in young patients irrespective of the status of MTHFR C677T...
  3. ncbi request reprint Homocysteine and outcome in young patients with acute coronary syndromes
    Francisco Martin-Herrero
    Cardiology Department, University Hospital, Salamanca, Spain
    Int J Cardiol 118:183-8. 2007
    ..Despite the well-known pro-thrombotic and pro-inflammatory plasma homocysteine effects, it remains uncertain whether these effects can be associated with an adverse cardiac outcome in young patients admitted with acute coronary syndromes...